This High-Rated Drug Stock Just Neared A Buy Point

By | March 12, 2015

Scalper1 News

Going into Thursday trading, Mylan (MYL) stock stands a chance of entering buy range. Shares closed up 6.7% Wednesday at 59, briefly rising past a buy point of 59.70 during the day, after product launches and chatter about whether it could be for sale, maybe to Teva Pharmaceutical Industries (TEVA). Mylan stock opened at 59.07 Thursday morning and was trading at 59.55 early on. Mylan is among top-rated stocks in the generic drugs industry, along Scalper1 News

Scalper1 News